Protagonist Therapeutics Inc (PTGX) earnings · rev $46.0M
These earnings events as JSON? API free 100/dayProtagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
This PTGX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported PTGX revenue for 2025-12-31 was $46.0M. Net income was -$130.1M. Revenue was down 89.4% from 2024-12-31 to 2025-12-31. PTGX currently screens at market cap $7.25B.
When the next PTGX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 89.4% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full PTGX research stays on the stock page; the tape stays on the quote page.
PTGX earnings FAQ
What are PTGX's latest revenue and net income?
Latest cached Protagonist Therapeutics Inc (PTGX) revenue for Dec 31, 2025 was $46.0M. Net income was -$130.1M. Statements: https://lician.com/financials/ptgx
What is PTGX's latest diluted EPS?
Latest cached Protagonist Therapeutics Inc (PTGX) diluted EPS for Dec 31, 2025 was -$2.05.
What period does the latest PTGX earnings print cover?
The latest cached Protagonist Therapeutics Inc (PTGX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did PTGX revenue change from the prior cached period?
Cached Protagonist Therapeutics Inc (PTGX) revenue was down 89.4% from $434.4M (Dec 31, 2024) to $46.0M (Dec 31, 2025). Statements: https://lician.com/financials/ptgx
Where are PTGX earnings listed?
Cached earnings facts for Protagonist Therapeutics Inc (PTGX) are listed at https://lician.com/earnings/ptgx. Statements: https://lician.com/financials/ptgx
Not investment advice.